21 Dec 2010 16:36
21 December 2010
OMEGA DIAGNOSTICS GROUP PLC
("OMEGA DIAGNOSTICS" OR THE "COMPANY")
Total Voting Rights
In conformity with the FSA's Disclosure and Transparency Rules, the Company notifies the market of the following:
As at the date of this announcement, the Company's issued share capital consists of 85,216,257 ordinary shares with a nominal value of 4 pence each ('Ordinary Shares'), with voting rights.
The Company does not hold any Ordinary Shares in Treasury.
The above figure of 85,216,257 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FSA's Disclosure and Transparency Rules.
For further information please contact:
Omega Diagnostics Group plc | Tel: 01259 763 030 |
Andrew Shepherd, Chief Executive | |
Kieron Harbinson, Group Finance Director | www.omegadiagnostics.com |
Cenkos Securities plc | Tel: 020 7397 8900 |
Ian Soanes | |
Elizabeth Bowman | |
Walbrook PR Limited | Tel: 020 7933 8780 |
Fiona Henson | fiona.henson@walbrookpr.com |
Helen Westaway | helen.westaway@walbrookpr.com |
Paul Cornelius | Tel: 020 7933 8794 |